6:00 PM
 | 
Oct 04, 2012
 |  BC Extra  |  Politics & Policy

France launching regulatory process for off-label use

France is implementing a regulatory process to temporarily authorize the use of selected drugs in off-label indications, according to a paper published in The New England Journal of Medicine by members of the country's revamped drug regulatory agency.

Under...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >